McKinsey & Company at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

McKinsey & Company takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its program centres on vaccine clinical development and where it gets stuck. Alongside PATH, Sanofi and AstriVax, it looks at how to reengineer the process to clear those bottlenecks.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
mckinsey.com
Consulting & servicesSilver sponsor
Global management consulting firm.
Booth
Exhibiting (no floor booth listed)
Talk
Wed Oct 21
12:45
Panel: From Bottleneck to Breakthrough: Reengineering Vaccine Clinical Development
Why vaccine development has slowed back to pre-pandemic speeds and which changes, including AI, could make clinical trials faster.
with PATH, Sanofi, AstriVax

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from McKinsey & Company

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction